Privia Health Group (NASDAQ:PRVA) Coverage Initiated at BTIG Research

Research analysts at BTIG Research initiated coverage on shares of Privia Health Group (NASDAQ:PRVAGet Rating) in a research report issued to clients and investors on Thursday, The Fly reports. The brokerage set a “buy” rating on the stock.

A number of other equities analysts have also recently weighed in on PRVA. Zacks Investment Research upgraded Privia Health Group from a “sell” rating to a “hold” rating in a report on Friday, March 25th. Jefferies Financial Group initiated coverage on Privia Health Group in a report on Monday, January 3rd. They set a “buy” rating and a $33.00 target price for the company. Cowen upgraded Privia Health Group from a “market perform” rating to an “outperform” rating and set a $35.00 price objective for the company in a research note on Tuesday, February 22nd. Canaccord Genuity Group decreased their price objective on Privia Health Group from $50.00 to $44.00 and set a “buy” rating for the company in a research note on Thursday, March 24th. Finally, Guggenheim initiated coverage on Privia Health Group in a research report on Tuesday, March 29th. They set a “buy” rating and a $35.00 target price on the stock. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $41.80.

Shares of PRVA opened at $24.07 on Thursday. Privia Health Group has a 52-week low of $18.93 and a 52-week high of $50.77. The company has a market capitalization of $2.60 billion and a PE ratio of -13.23. The stock has a fifty day simple moving average of $25.46 and a two-hundred day simple moving average of $24.73. The company has a quick ratio of 2.35, a current ratio of 2.35 and a debt-to-equity ratio of 0.07.

Privia Health Group (NASDAQ:PRVAGet Rating) last released its quarterly earnings results on Wednesday, March 23rd. The company reported ($0.11) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.02. Privia Health Group had a negative return on equity of 54.01% and a negative net margin of 19.48%. As a group, equities analysts anticipate that Privia Health Group will post 0.11 earnings per share for the current fiscal year.

In other Privia Health Group news, COO Parth Mehrotra sold 20,000 shares of Privia Health Group stock in a transaction dated Tuesday, February 22nd. The shares were sold at an average price of $25.30, for a total transaction of $506,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Thomas Bartrum sold 10,000 shares of Privia Health Group stock in a transaction dated Wednesday, April 20th. The stock was sold at an average price of $27.93, for a total transaction of $279,300.00. Following the transaction, the executive vice president now owns 27,391 shares of the company’s stock, valued at approximately $765,030.63. The disclosure for this sale can be found here. In the last three months, insiders have sold 95,288 shares of company stock worth $2,482,053.

Institutional investors and hedge funds have recently made changes to their positions in the business. Rockefeller Capital Management L.P. acquired a new position in Privia Health Group during the fourth quarter worth about $25,000. First Horizon Advisors Inc. acquired a new position in shares of Privia Health Group in the fourth quarter valued at approximately $26,000. FourThought Financial LLC acquired a new position in shares of Privia Health Group in the third quarter valued at approximately $32,000. Royal Bank of Canada acquired a new position in shares of Privia Health Group in the second quarter valued at approximately $74,000. Finally, Gleason Group Inc. acquired a new position in shares of Privia Health Group in the first quarter valued at approximately $57,000. Institutional investors own 53.88% of the company’s stock.

About Privia Health Group (Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Further Reading

The Fly logo

Analyst Recommendations for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.